CHNXF.US ChitogenX Inc.
- Market cap
- USD 628K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Oct 2024.
Is CHNXF.US undervalued?
Graham numberThe Graham number of ChitogenX Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ChitogenX Inc. fundamental analysis
No fundamental analysis for ChitogenX Inc. yet.
ChitogenX Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ChitogenX Inc.
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 202…
Full company profileChitogenX Inc. financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 3 quarters up to Oct 31, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
ChitogenX Inc. annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -2.31M | -2.18M | -2.93M | -3.26M | -4.71M | -2.74M | -785K |
| EBITDA | -2.16M | -2.02M | -2.85M | -3.72M | -4.86M | -670K | - |
| Net Income | -2.40M | -2.49M | -3.77M | -4.92M | -6.23M | -1.55M | -1.46M |
| EPS | -0.10 | -0.10 | -0.11 | -0.14 | -0.12 | -0.02 | -0.02 |
| Balance Sheet | |||||||
| Total Assets | 1.60M | 1.29M | 3.28M | 1.12M | 738K | 534K | 385K |
| Total Liabilities | 2.19M | 3.69M | 5.08M | 8.23M | 10.6M | 6.71M | 7.75M |
| Shareholders' Equity | -589K | -2.40M | -1.80M | -7.10M | -9.84M | -6.18M | -7.36M |
| Cash & Short-term Investments | 524K | 302K | 2.38M | 313K | 108K | 35.0K | 48.0K |
| Cash Flow | |||||||
| Operating Cash Flow | -1.39M | -1.59M | -2.98M | -3.22M | -3.20M | -1.01M | -82.7K |
| Capital Expenditure | 75.0K | 3.00K | 3.00K | 33.0K | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -1.46M | -1.59M | -2.98M | -3.25M | -3.20M | -1.01M | -82.7K |
| Ratios | |||||||
| ROA | -149.6% | -193.3% | -115.1% | -438.2% | -844.2% | -291.0% | -379.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
ChitogenX Inc. dividends
ChitogenX Inc. has not paid dividends in the last 6 fiscal years.
Who owns ChitogenX Inc.
- Insiders 0.00%
- Institutions 0.15%
- Public & others 99.85%
- Shares outstanding 83.1M
- Free float 78.8M
ChitogenX Inc. company profile
- Company name
- ChitogenX Inc.
- Ticker
- CHNXF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Fiscal year end
- January
- Address
- 16667 Hymus Boulevard, Kirkland, QC, Canada, H9H 4R9
- Phone
- 514 261 4735
- Website
- chitogenx.com
About ChitogenX Inc.
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
ChitogenX Inc. management
6- Mr. Pierre Laurin B.Sc.Pharm., M.Sc.Interim CEO & Chairman · born 1961
- Mr. Luc Mainville M.B.A.Senior VP & CFO · born 1964
- Mr. Guy-Paul AllardVP of Legal Affairs & Corporate Secretary
- Dr. Jonathan SackierSenior Vice President of Medical Affairs
- Mr. Frédéric DumaisDirector of Communications & Investor Relations
- Mr. Benedek SimoController